Standout Papers
- Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease (1999)
- Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2002)
- Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. (1996)
- Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. (1998)
- Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer (2019)
- Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment (2017)
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update (2024)
Immediate Impact
17 by Nobel laureates 7 from Science/Nature 142 standout
Citing Papers
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of Debu Tripathy being referenced
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment
2021
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
2019 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Debu Tripathy | 10360 | 3594 | 2940 | 4170 | 4129 | 414 | 15.4k | |
| Evandro de Azambuja | 10394 | 3489 | 4530 | 2482 | 3047 | 346 | 14.9k | |
| Aditya Bardia | 10465 | 5194 | 4867 | 1682 | 3865 | 468 | 15.3k | |
| Julie R. Gralow | 12174 | 4063 | 5389 | 4416 | 3892 | 277 | 19.8k | |
| Melody Cobleigh | 10293 | 2780 | 3687 | 2943 | 4216 | 130 | 14.4k | |
| Hans Wildiers | 7289 | 3163 | 3358 | 1592 | 2679 | 382 | 14.1k | |
| Alberto Ocaña | 7114 | 2462 | 2453 | 1626 | 3696 | 296 | 12.0k | |
| John Crown | 12728 | 4664 | 5824 | 2293 | 7262 | 413 | 19.6k | |
| Sabino De Placido | 7699 | 4412 | 3698 | 1608 | 4332 | 376 | 13.7k | |
| Nancy U. Lin | 10838 | 7494 | 3908 | 2226 | 3343 | 368 | 16.5k | |
| John R. Mackey | 14473 | 4467 | 3908 | 1835 | 5741 | 328 | 23.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...